Abstract: An anode for a secondary battery includes an anode current collector, a first anode active material layer disposed on at least one surface of the anode current collector and including a first anode active material that includes a first silicon composite oxide, and a second anode active material layer disposed on the first anode active material layer and including a second anode active material that includes a second silicon composite oxide. Each of the first silicon composite oxide and the second silicon composite oxide includes a metal. A BET specific surface area of each of the first silicon composite oxide and the second silicon composite oxide is in a range from 2.0 m2/g to 6.5 m2/g.

Abstract: Proposed is a method for providing an emoticon input interface by a user terminal. The method may include displaying a first input interface for inputting an emoticon to be posted on a profile page of a user. The method may also include receiving a selection interaction of selecting a first emoticon to be posted on the profile page of the user via the first input interface, and displaying the selected first emoticon on the profile page of the user. The first input interface may include user custom information associated with emoticon historical information of the user. The user custom information may be identical to at least a part of user custom information for a second input interface for inputting an emoticon to be displayed in a chat message.

Abstract: The present invention relates to a novel benzopyran derivative useful for preparing a drug for treating cancer, and more specifically, to a novel benzopyran derivative which is a micromolecule having a macrophage inhibitory effect and is useful for preparing a drug for cancer treatment. The drug particularly inhibits the differentiation of immune macrophages to stimulate the immune system, and thus is useful for treating immune-related cancers.

Abstract: An aluminum alloy-plated steel sheet having excellent workability and corrosion resistance and a method for manufacturing the same are disclosed. The aluminum alloy-plated steel sheet includes a base sheet, and an alloy-plated layer formed on the base sheet. Interfacial roughness between the alloy-plated layer and the base steel sheet is 25 ?m or less. Such an aluminum alloy-plated steel sheet prevents microcracks generated during hot forming and has excellent seizure resistance and corrosion resistance. A method for manufacturing such an aluminum alloy-plated steel is also disclosed.

Abstract: A conductive particle to be dispersed in a resin composition of an anisotropic connection material containing binder resin and solvent, the conductive particle includes: a core, a conductive layer provided on the core and containing metal, insulating fine particles connected by a first substituent that binds to the metal of the conductive layer, provided on a first region of the conductive layer, and a hydrophobic surface treatment layer connected by a second substituent that binds to the metal of the conductive layer, provided on a second region of the conductive layer, wherein the first region and the second region do not overlap.

Abstract: An image processing apparatus and method. For example, an image processing apparatus for distinguishing between an area of interest and an area of non-interest in an image, the image processing apparatus comprises: a memory configured to store a second image including information on an area of non-interest, an area of interest, and a variable area; a receiver configured to receive a first image captured from at least one camera; and a processor including an artificial intelligence model trained to distinguish objects in an area of interest of the first image from a input data, consisting of the second image and the first image, wherein the processor extracts information on an area of non-interest from a resultant image, outputted by the artificial intelligence model, and updates a size of the variable area of the second image using an extracted information on the area of non-interest.

Abstract: The present invention relates to a continuously variable transmission, and more specifically, to a continuously variable transmission that prevents power cut-off when shifting and minimizes a load/impact due to the shifting, and that includes an eccentric disk and an output shaft which rotate in the same direction to prevent noise/vibration/impact that is generated particularly when the eccentric disk that operates a link actuator and the output shaft rotate in opposite directions.

Abstract: Provided is a conductive material dispersion comprising single-walled carbon nanotubes, a dispersant, a dispersion aid, and a dispersion medium, wherein the dispersant comprises polyvinyl butyral and hydrogenated nitrile butadiene rubber, and the dispersion aid comprises a compound represented by Formula 1. A-(R)n??[Formula 1] In Formula 1, A is a structure having a carbon number of 16 to 50 carbon number and comprising four or more aromatic rings and nitrogen, R is a structure comprising an anionic functional group, and n is an integer of 1 to 5.

Abstract: The present invention pertains to an anticancer composition containing IF1 (ATPase inhibitory factor 1). The IF1 (ATPase inhibitory factor 1) according to the present invention has the effect of releasing extracellular ATP, induces cytotoxicity in various cancer cells and exhibits anticancer efficacy, and is thus very useful as an active ingredient of a powerful anticancer agent.

Abstract: The present invention pertains to an anticancer composition containing IF1 (ATPase inhibitory factor 1). The IF1 (ATPase inhibitory factor 1) according to the present invention has the effect of releasing extracellular ATP, induces cytotoxicity in various cancer cells and exhibits anticancer efficacy, and is thus very useful as an active ingredient of a powerful anticancer agent.

Abstract: The present invention relates to a pharmaceutical composition which is for preventing or treating obesity, and comprises a biglycan as an active ingredient. Biglycan according to the present invention suppresses appetite by decreasing the expression of Agrp and NPY, which are appetite promoting peptides, and increasing the expression of POMC, which is an appetite suppressing peptide, and thus is very useful as a medicine for treating obesity.

Abstract: Described herein is a sesquiterpene derivative or a pharmaceutically acceptable salt thereof, a composition for preventing, ameliorating or treating sarcopenia, including the derivative or salt thereof as an active ingredient, and the like. The sesquiterpene derivative or pharmaceutically acceptable salt thereof inhibits increases in the production and mRNA expression of a myostatin protein, which directly affects muscle loss and reduced muscle strength, and thus may exhibit a more fundamental effect of preventing or treating sarcopenia.

Abstract: Provided are a method for preparing chiral nitro derivatives using organic chiral catalyst compounds and water as an eco-friendly solvent, and the like. The catalyst is an organic catalyst based on (R,R)-1,2-diphenylethylenediamine (DPEN), and can prepare nitro derivatives having enantioselectivity and diastereoselectivity in excellent yield through a hydrophobic hydration effect. In particular, the preparation method of the present disclosure can stabilize a transition state through an interfacial reaction between the catalyst and water. In addition, indole derivatives can be synthesized using the chiral nitro derivatives prepared according to the present disclosure to be usefully used for the prevention or treatment of brain-nervous system diseases including depression and muscular diseases including cachexia.

Abstract: Provided are a method for preparing chiral maleimide derivatives using (R,R)-1,2-diphenylethylenediamine (DPEN)-based organic chiral catalyst compounds and water as an eco-friendly solvent, and the like. It is possible to prepare chiral maleimide derivatives having high enantioselectivity even with a small amount of catalyst in an excellent yield within a short time. In particular, the preparation method of the present disclosure can stabilize a transition state through an interfacial reaction between the catalyst and water. In addition, spironolactone derivatives are synthesized using chiral maleimide derivatives prepared according to the present disclosure to be usefully used for the treatment of edema control, heart failure, liver cirrhosis, electrolyte abnormalities, hypertension, etc.

Abstract: According to an embodiment of the present invention, provided is a composition for preventing or treating sarcopenia containing a non-natural amino acid derivative as an active ingredient.

Abstract: According to one embodiment of the present invention, provided is a composition for preventing or treating sarcopenia, containing, as an active ingredient, at least one type of unnatural amino acid selected from the group consisting of D-leucine, D-alanine and D-proline.

Abstract: The present invention relates to a pharmaceutical composition which is for preventing or treating obesity, and comprises a biglycan as an active ingredient. Biglycan according to the present invention suppresses appetite by decreasing the expression of Agrp and NPY, which are appetite promoting peptides, and increasing the expression of POMC, which is an appetite suppressing peptide, and thus is very useful as a medicine for treating obesity.

Abstract: The present invention relates to a composition for preventing or treating obesity or sarcopenia, containing ATPase inhibitory factor 1 (IF1) and, more specifically, to a pharmaceutical composition and a food for preventing or treating obesity or sarcopenia, containing, as an active ingredient, IF1 having an effect of suppressed appetite or effects increased muscle mass and muscle production. According to the present invention, ATPase inhibitory factor 1 (IF1) exhibits, in an obesity-induced mouse model, effects of inhibited weight gain and decreased dietary intake without side effects, and exhibits, in obesity-induced or aged mouse, effects of increased muscle mass, increased muscle protein and muscle production, and thus is very useful as an agent for preventing, alleviating or treating metabolic diseases such as obesity, an agent for suppressing appetite and an agent for preventing, alleviating or treating muscle loss-related diseases such as sarcopenia.

Abstract: The present invention pertains to an anticancer composition containing IF1 (ATPase inhibitory factor 1). The IF1 (ATPase inhibitory factor 1) according to the present invention has the effect of releasing extracellular ATP, induces cytotoxicity in various cancer cells and exhibits anticancer efficacy, and is thus very useful as an active ingredient of a powerful anticancer agent.

Abstract: An electric vehicle charging control system may include an electric vehicle which extracts current time information, the integrity of which has been verified, by use of a public key cryptography, and charges power from a charging terminal, when it is determined that a charging contact certificate is valid, based on the extracted current time information, a server to transmit the current time information, the integrity of which has been verified using the public key cryptography, to the electric vehicle, and the charging terminal connected to the electric vehicle. The validity of the certificate used in vehicle charging and billing for charging is determined through the power line communication, and the security against the hacking is enhanced in the charging of the electric vehicle.